Main Session
Sep
29
SS 23 - GU 5: Milestones in Metastatic Prostate Cancer
240 - Efficacy and Safety of All-Site Radiation Therapy and Standard of Care Therapy with or without Docetaxel for Hormone-Sensitive High Gleason Score Prostate Cancer: 6-Year Results from a Long-Term Study
Presenter(s)
Huizhu Chen, BS - Peking University First Hospital, Beijing,